As of Aug 23
| -0.06 / -1.98%|
The 1 analysts offering 12-month price forecasts for ARCA Biopharma Inc have a median target of 16.50, with a high estimate of 16.50 and a low estimate of 16.50. The median estimate represents a +455.56% increase from the last price of 2.97.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.